Who invested in Cynapsus Therapeutics?
Cynapsus Therapeutics's investors include Venrock, OrbiMed and Aisling Capital.

Canada · Venture startup
5 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Cynapsus Therapeutics and see its new rounds in your feed.Start following
Funding summaryUpdated 31 Oct 2026
$37Mraised across 5 rounds since 2012, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding recordSEC filing: $17M sold, first sale Mar 2015
No investor was named in the report.
From a historical funding recordSEC filing: $15M sold, first sale Apr 2014
No investor was named in the report.
From a historical funding recordSEC filing: $15M sold, first sale Apr 2014
No investor was named in the report.
Reported by sec.govSEC filing: $4.1M sold, first sale Mar 2013
No investor was named in the report.
Reported by docs.google.comSEC filing: $940K sold, first sale Sept 2011
From Cynapsus Therapeutics's own website: 3 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Cynapsus Therapeutics's investors include Venrock, OrbiMed and Aisling Capital.
Cynapsus Therapeutics has raised $37M across 5 rounds since 2012.
Cynapsus Therapeutics's most recent round was a Venture of $17M in Mar 2015.
Its most recent round, $17M in Mar 2015, is also its largest on record.
Cynapsus Therapeutics's first round on record, in Mar 2015, was backed by Venrock, OrbiMed and Aisling Capital.
Cynapsus Therapeutics's latest named round is a Venture, in Mar 2015.
Cynapsus Therapeutics is based in Canada.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.